We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Mitochondrial Dysfunction in Metabolic Dysfunction Fatty Liver Disease (MAFLD).
- Authors
Zhao, Ying; Zhou, Yanni; Wang, Dan; Huang, Ziwei; Xiao, Xiong; Zheng, Qing; Li, Shengfu; Long, Dan; Feng, Li
- Abstract
Nonalcoholic fatty liver disease (NAFLD) has become an increasingly common disease in Western countries and has become the major cause of liver cirrhosis or hepatocellular carcinoma (HCC) in addition to viral hepatitis in recent decades. Furthermore, studies have shown that NAFLD is inextricably linked to the development of extrahepatic diseases. However, there is currently no effective treatment to cure NAFLD. In addition, in 2020, NAFLD was renamed metabolic dysfunction fatty liver disease (MAFLD) to show that its pathogenesis is closely related to metabolic disorders. Recent studies have reported that the development of MAFLD is inextricably associated with mitochondrial dysfunction in hepatocytes and hepatic stellate cells (HSCs). Simultaneously, mitochondrial stress caused by structural and functional disorders stimulates the occurrence and accumulation of fat and lipo-toxicity in hepatocytes and HSCs. In addition, the interaction between mitochondrial dysfunction and the liver–gut axis has also become a new point during the development of MAFLD. In this review, we summarize the effects of several potential treatment strategies for MAFLD, including antioxidants, reagents, and intestinal microorganisms and metabolites.
- Subjects
FATTY liver; METABOLIC disorders; NON-alcoholic fatty liver disease; MITOCHONDRIA; VIRAL hepatitis
- Publication
International Journal of Molecular Sciences, 2023, Vol 24, Issue 24, p17514
- ISSN
1661-6596
- Publication type
Article
- DOI
10.3390/ijms242417514